High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination

Leuk Lymphoma. 2022 Oct;63(10):2484-2488. doi: 10.1080/10428194.2022.2074988. Epub 2022 May 20.
No abstract available

Keywords: COVID-19 vaccination; hematologic malignancies; minorities.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Hematologic Neoplasms* / therapy
  • Hispanic or Latino
  • Humans
  • SARS-CoV-2
  • Seroconversion
  • Vaccination / adverse effects

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines